Hard to Treat Diseases (HTDS)

[just Scottie]

Very interesting, this investment firm that manages $888,615,000 USD owns over 1.4 billion shares of HTDS according to 13F Fund Filings

This form was filed on 2020-11-10.

Smith Chas P & Associates Pa Cpas has disclosed 91 total holdings in their latest SEC filings. Most recent portfolio value is calculated to be $ 888,615,000 USD. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Smith Chas P & Associates Pa Cpas's top holdings are Apple, Inc. (US:AAPL) , PowerShares QQQ Trust (US:QQQ) , Microsoft Corp. (US:MSFT) , Berkshire Hathaway, Inc. (US:BRK.B) , and Home Depot, Inc. (The) (US:HD) . Smith Chas P & Associates Pa Cpas's new positions include UnitedHealth Group Inc. (US:UNH) , Deere & Co. (US:DE) , Innovation Pharmaceuticals Inc (US:IPIX) , Medical Marijuana, Inc. (US:MJNA) , and .

https://fintel.io/i/smith-chas-p-associates-pa-cpas

Institutional Ownership and Shareholders

HTDS / Hard to Treat Diseases, Inc. Institutional Ownership
Hard to Treat Diseases, Inc. (US:HTDS) has 2 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,605,360 shares. Largest shareholders include Smith Chas P & Associates Pa Cpas, and Fisher Asset Management, LLC.

Hard to Treat Diseases, Inc. (US:HTDS) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.

https://fintel.io/so/us/htds